[Gastroesophageal reflux as a cause of pulmonary dysfunction after lung transplantation]

Masanori Tsuchida1, T Hashimoto, H Shinohara

  • 1Division of Thoracic and Cardiovascular Surgery, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.

Insights

Gastroesophageal reflux can impair lung transplant outcomes. Surgical correction via fundoplication improved lung function in a teenage patient with interstitial lung disease post-transplant.

Area of Science:

  • Transplantation immunology
  • Gastroenterology
  • Pulmonary medicine

Background:

  • Gastroesophageal reflux (GER) is a known risk factor for allograft dysfunction in lung transplant recipients.
  • Microaspiration, inflammation, and obliterative bronchiolitis are potential consequences of GER post-lung transplant.

Observation:

  • A 16-year-old male with interstitial lung disease underwent bilateral lung transplantation.
  • Post-transplant, the patient exhibited significantly reduced lung function (FVC 33%, FEV1 28% predicted).
  • Gastroesophageal reflux was identified as the sole positive finding after extensive investigation.

Findings:

  • Initial pyeloplasty failed to improve lung function, with persistent GER confirmed by pH monitoring.
  • Laparoscopic fundoplication 9 months post-transplant led to gradual improvement in lung function (FVC 44%, FEV1 33% predicted).

Implications:

  • This case highlights the critical role of managing gastroesophageal reflux in lung transplant recipients.
  • Surgical intervention, specifically fundoplication, can be effective in improving allograft function when GER is a contributing factor.
  • Early identification and management of GER may improve long-term outcomes for lung transplant patients.

Related Concept Videos

Gastroesophageal Reflux Disease01:25

Gastroesophageal Reflux Disease

Gastroesophageal reflux disease (GERD) is the backward flow of stomach contents (acid, pepsin, or bile) into the esophagus, causing mucosal inflammation known as esophagitis. It results from failure of antireflux mechanisms, mainly the lower esophageal sphincter (LES), influenced by mechanical and physiological factors.Etiology and Risk FactorsGERD develops when LES function is weakened or when intra-abdominal pressure increases. Risk factors include aging, obesity, and sliding hiatal hernia,...
Gastroesophageal Reflux Disease I: Meaning and Pathophysiology01:29

Gastroesophageal Reflux Disease I: Meaning and Pathophysiology

Gastroesophageal Reflux Disease (GERD) involves the recurrent backflow of the stomach or duodenal contents into the esophagus, leading to troublesome symptoms and potential esophageal mucosal damage. Although GERD is often referred to as a disease, it is more accurately described as a syndrome, as it encompasses a range of symptoms and complications rather than a singular pathological entity, impacting a large number of individuals as the most prevalent upper gastrointestinal problem. Roughly...
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
Gastroesophageal Reflux Disease II: Clinical Features and Management01:29

Gastroesophageal Reflux Disease II: Clinical Features and Management

Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Esophageal Achalasia01:27

Esophageal Achalasia

Esophageal achalasia is a chronic neurogenic disorder characterized by impaired relaxation of the lower esophageal sphincter (LES) and absent or ineffective peristalsis in the distal esophagus. This leads to a functional obstruction without a physical blockage, despite significant disruption of esophageal motility.EtiologyAchalasia is caused by degeneration of the myenteric (Auerbach's) plexus, specifically the loss of inhibitory ganglion cells that produce vasoactive intestinal peptide (VIP)...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...